Ertugliflozin vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
Clinical trial NCT01999218 · COMPLETED
Trial details
- NCT number
- NCT01999218
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-16
- Primary completion
- 2017-04-18
- Enrollment
- 1326
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.